JoVE maandelijkse hoogtepunten december 2017
11 december 2017
1.3K weergaven
Overview
This preview highlights key articles featured in the December 2017 issue of JoVE, spanning advances in medical treatment, neuroscience, developmental biology, and chemistry. The issue showcases innovative protocols and experimental approaches with significant implications for clinical practice and scientific research.
Key Study Components
Area of Science
- Medicine
- Neuroscience
- Developmental Biology
- Chemistry
Background
- Essential tremor is a neurological disorder that can be treated with focused ultrasound therapy.
- Capillary refill tests are commonly used to assess circulatory status in critically ill patients.
- Genome editing in non-model organisms like the jewel wasp Nasonia vitripennis presents technical challenges.
- Understanding nuclear reactor core meltdown processes is vital for nuclear safety.
Purpose of Study
- To demonstrate a customizable MRI-guided focused ultrasound protocol for essential tremor treatment.
- To introduce a quantitative method for assessing capillary refill using diffuse polarization spectroscopy.
- To establish a microinjection protocol for CRISPR/Cas9 delivery in jewel wasp embryos.
- To simulate and analyze the formation of lava-phase materials during nuclear reactor core meltdown.
Methods Used
- MRI-guided focused ultrasound treatment with detailed patient selection and follow-up.
- Video-based measurement of capillary refill using diffuse polarization spectroscopy.
- Microinjection of CRISPR/Cas9 into Nasonia vitripennis embryos extracted from host pupae.
- High-temperature laboratory experiments with real nuclear fuel and containment materials.
Main Results
- Immediate and sustained reduction in tremors for patients treated with focused ultrasound.
- Improved accuracy in monitoring circulation compared to traditional visual capillary refill tests.
- Successful genome modification in jewel wasp embryos, overcoming previous technical barriers.
- New insights into material behavior during nuclear reactor core meltdown, informing accident prevention.
Conclusions
- Innovative protocols can enhance clinical outcomes and research capabilities across disciplines.
- Quantitative and precise methodologies improve diagnostic and experimental reliability.
- Advances in genome editing and nuclear safety research have broad scientific and practical impact.
Frequently Asked Questions
What is MRI-guided focused ultrasound and how does it help essential tremor patients?
MRI-guided focused ultrasound is a non-invasive treatment that uses targeted ultrasound waves to ablate brain tissue responsible for tremors, resulting in immediate and long-term symptom reduction.
How does diffuse polarization spectroscopy improve the capillary refill test?
This technique quantitatively measures capillary refill using video analysis, providing more accurate and objective assessments than traditional visual observation.
Why is microinjection of CRISPR/Cas9 into jewel wasp embryos significant?
It enables precise genome editing in Nasonia vitripennis, facilitating genetic studies in this and related species that were previously difficult to manipulate.
What are the implications of simulating lava-phase formation in nuclear reactor meltdowns?
These experiments help scientists understand material behavior at extreme temperatures, contributing to improved safety protocols and accident prevention in nuclear power plants.
Are these protocols accessible to other researchers?
Yes, JoVE articles provide detailed, video-based protocols designed to be reproducible by researchers in relevant fields.
What is the benefit of video-based protocols in scientific research?
Video protocols enhance clarity, reproducibility, and accessibility, allowing researchers to accurately replicate complex procedures.
Where can I access the full articles and protocols?
Full-length articles and protocols are available on the JoVE website.
Executive Industry Relevance
The December 2017 JoVE highlights showcase protocols with direct translational value for biopharma R&D, including quantitative diagnostics, genome editing in non-model organisms, and advanced simulation of extreme conditions. These innovations support predictive confidence, mechanistic de-risking, and workflow standardization across early discovery and translational research. The featured methods enable more reliable target validation, assay development, and cross-disciplinary integration within enterprise portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Quantitative capillary refill measurement enhances physiological biomarker validation for circulatory assessment.
- CRISPR/Cas9 microinjection in jewel wasp embryos expands genetic manipulation capabilities to new model systems.
- Simulation of nuclear meltdown materials informs risk assessment for extreme condition modeling.
Screening & Assay Development
- Video-based capillary refill protocols enable reproducible, quantitative readouts for diagnostic assay development.
- Standardized microinjection workflows facilitate scalable genome editing experiments.
- High-temperature simulation protocols provide reference data for material screening under stress conditions.
Translational & Preclinical Research
- Quantitative circulatory monitoring supports translational biomarker alignment in critical care research.
- Genome editing in non-traditional organisms enables new preclinical models for functional genomics.
- Material behavior studies under meltdown conditions inform translational safety research.
Pipeline & Workflow Integration
These protocols bridge early discovery, assay development, and translational research by providing standardized, quantitative, and reproducible methods applicable across multiple R&D stages.
- Discovery Biology: Supports hypothesis testing and mechanistic de-risking through quantitative physiological and genetic assays.
- Screening: Enables assay readiness and reproducibility with video-based and standardized protocols.
- Analytics: Delivers quantitative outputs for robust comparison of experimental conditions.
- Translational Research: Facilitates continuity from discovery to preclinical validation, especially in biomarker and safety studies.
- Enterprise Reuse: Protocols are designed for broad adoption and adaptation across research teams and model systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target and biomarker validation.
- Operational Value: Promotes standardization, reproducibility, and scalability of complex protocols.
- Strategic Value: Enables informed go/no-go decisions and reduces late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of diverse R&D programs.
Implementation Considerations
- Requires expertise in quantitative imaging, genome editing, or high-temperature material analysis.
- Demands access to specialized instrumentation such as MRI, video analysis systems, or high-temperature reactors.
- Cross-team standardization is essential for reproducibility and data comparability.
- Adaptation may be needed for different model organisms or material systems.
- Protocols are designed for reproducibility but may have practical limitations based on infrastructure.
Biopharma FAQs
Why does null hypothesis testing matter for capillary refill quantification?
Null hypothesis testing in quantitative capillary refill protocols enables objective assessment of circulatory status, supporting robust target validation for diagnostic biomarkers and reducing subjective bias in early discovery workflows.
How does independent variable isolation apply in CRISPR/Cas9 microinjection?
Isolating variables in jewel wasp embryo microinjection ensures that observed genome modifications are attributable to CRISPR/Cas9 delivery, strengthening mechanistic confidence and supporting reproducible genetic studies in new model systems.
What do quantitative dependent variable measurements enable in video-based assays?
Quantitative video-based measurements of capillary refill provide precise, reproducible data for comparing circulatory responses, enabling reliable assay development and facilitating cross-study analytics in translational research.
Why are replication requirements critical for high-temperature meltdown simulations?
Replication in nuclear meltdown material experiments ensures data reliability and cross-functional comparability, supporting collaborative safety research and informing enterprise-level risk assessment strategies.
What statistical analysis capabilities are needed before implementing these protocols?
Robust statistical analysis is required to validate quantitative outputs, assess reproducibility, and support decision-making across discovery, screening, and translational research pipelines.